Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
M.D. Anderson Cancer Center
West Virginia University
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Columbia University
University of Illinois at Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sichuan University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Massachusetts General Hospital
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
University of Arizona
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
King's College Hospital NHS Trust
Otsuka Pharmaceutical Development & Commercialization, Inc.
University of Virginia
National Cancer Institute (NCI)
Northside Hospital, Inc.
Texas Oncology Cancer Center
Northside Hospital, Inc.
Case Comprehensive Cancer Center
Targazyme, Inc.